USD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$487.08M
Market Cap
-
P/E Ratio
-1.58
EPS
$12.98
52 Week High
$3.49
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $2.5B |
| Total Current Assets | $607M |
| Cash And Cash Equivalents At Carrying Value | $104M |
| Cash And Short Term Investments | $104M |
| Inventory | - |
| Current Net Receivables | $415M |
| Total Non Current Assets | $1.9B |
| Property Plant Equipment | $79M |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $680M |
| Intangible Assets Excluding Goodwill | $680M |
| Goodwill | $1.1B |
| Investments | - |
| Long Term Investments | $8.6M |
| Short Term Investments | $59M |
| Other Current Assets | $29M |
| Other Non Current Assets | - |
| Total Liabilities | $1.5B |
| Total Current Liabilities | $716M |
| Current Accounts Payable | $96M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $198M |
| Total Non Current Liabilities | $828M |
| Capital Lease Obligations | $52M |
| Long Term Debt | $491M |
| Current Long Term Debt | $171M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $714M |
| Other Current Liabilities | $419M |
| Other Non Current Liabilities | $3M |
| Total Shareholder Equity | $1B |
| Treasury Stock | - |
| Retained Earnings | -$781M |
| Common Stock | $1.2M |
| Common Stock Shares Outstanding | $115M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $19M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $126M |
| Capital Expenditures | $25M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$63M |
| Cashflow From Financing | -$565K |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $20M |
| Dividend Payout Common Stock | $20M |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$17M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$62M |
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
Evolent Health, Inc. is a leading healthcare technology and services provider headquartered in Arlington, Virginia, focused on transforming healthcare delivery and financing across the United States. By offering innovative solutions like integrated care management and population health services, Evolent empowers healthcare organizations to improve patient outcomes and lower costs. Its comprehensive platform facilitates value-based care initiatives, enabling providers to successfully navigate the complexities of the healthcare system. With a strong emphasis on delivering measurable results through clinical insights and operational efficiencies, Evolent Health is well-positioned to spearhead the evolution of the healthcare landscape in an increasingly complex environment.